Market Research Report
Cough, Cold & Allergy Report - Exploring the Current & Future Self-Care CCA Market
|Cough, Cold & Allergy Report - Exploring the Current & Future Self-Care CCA Market|
Published: November 4, 2020
Nicholas Hall & Company
Content info: 328 Pages
Delivery time: 1-2 business days
With global sales of over $29bn, the CCA market grew by 4.2% in 2019, just ahead of the global consumer healthcare market (+3.9%). The largest categories Systemic cold & flu and Cough remedies are mature, fragmented and hampered by safety concerns. Allergy remedies expanded via Rx-to-OTC switches in recent years but their impact may have peaked. Topical decongestants and Chest rubs & inhalants enjoyed the strongest performances in 2019.
But what is next for the CCA market? It is projected to be the fastest-growing category in 2020 (according to DB6 estimates), boosted by coronavirus and reports of a high incidence of seasonal cold & flu at the start of 2020, but as consumers in most countries filled their medicine chests in Q1, this may dampen demand for the rest of the year. Have lockdown and physical distancing measures reduced the incidence of flu, colds, and non-Covid viruses? The rest of the year remains unpredictable with a rapid return to normal or a second wave of Covid-19 distinct possibilities.
S&dragger;comprises Systemic decongestants (4%),Chest rubs & inhalants (3%),Asthma remedies (1%)